-- Aethlon Medical (NASDAQ: AEMD) reported third quarter 2020 net loss attributable to company of $820,000 or $0.28 per share vs. a
Aethlon Medical (AEMD) Q3 2020 Earnings Snapshot
Categories
Medical Devices
Boston Scientific Corporation (BSX): Q4 2019 Earnings Snapshot
-- Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected. -- Total
Stryker (SYK): Q4 2019 Earnings Snapshot
-- Stryker (NYSE: SYK) reported fourth quarter 2019 earnings of $2.49 per share, vs. $2.46 per share expected. -- Total sales grew
Johnson & Johnson (JNJ) beats Q4 earnings estimates, misses on revenue
Johnson & Johnson (NYSE: JNJ) topped earnings estimates for the fourth quarter of 2019 while revenues fell short of expectations. The shares
Abiomed’s (ABMD) revenue increases 13% in Q2 on higher usage of Impella; reiterates 2020 outlook
Abiomed (NASDAQ: ABMD) reported a 13% growth in second quarter 2020 revenue, boosted by the increased usage of its Impella heart pumps.
Stryker (SYK): Q3 2019 Earnings Snapshot
-- Stryker (NYSE: SYK) reported third-quarter 2019 earnings of $1.91 per share, vs. $1.90 per share expected. -- Total revenue grew 10.6%
Abbott Laboratories: Solid product line expected to boost Q3 results
There are few pharmaceutical companies as solid as Abbott Laboratories (NYSE: ABT). Thanks to the two major acquisitions it made a couple
Johnson & Johnson (JNJ) likely to feel the pinch in Q3
Johnson & Johnson (NYSE: JNJ) is slated to release its third-quarter earnings results on Tuesday, October 15, before the market opens. The
Medtronic posts upbeat Q1 results, raises EPS outlook
Irish medical technology firm Medtronic plc (NYSE: MDT) on Tuesday announced results for the first quarter of 2020 that were better than what
Agilent Technologies stock surges on Q3 earnings beat, lifts fiscal outlook
Agilent Technologies (NYSE: A) stock surged above 7% after the bell as the company raised its full-year headline numbers. Third quarter results
Boston Scientific Q2 profit dips 72% but beats estimates
Boston Scientific Corporation (NYSE: BSX) reported a 72% dip in earnings for the second quarter due to higher costs and expenses as well
Intuitive Surgical to report Q2 earnings tomorrow. What to watch
Medical device manufacturer Intuitive Surgical (NASDAQ: ISRG) is slated for second-quarter financial results on July 18, Thursday, after the closing bell. Analysts
Earnings preview: Abbott banks on medical devices for Q2 growth
Abbott Laboratories (NYSE: ABT) is set to release its earnings results for the second quarter of 2019 on Wednesday before the market
Aethlon Medical earnings preview: Cash crunch at its peak ahead of Q4 results
Aethlon Medical (NASDAQ: AEMD) is trading near an all-time low as it heads towards its fourth-quarter financial results, slated for Monday, July
Medtronic to announce Q4 results amidst pacemaker crisis
Medtronic (NYSE: MDT) is scheduled to report fourth-quarter 2019 financial results on Thursday, May 23, before the regular trading hours. The Dublin-based
InspireMD Q1 revenues plunge on third-party equipment failure
Israel-based medical device company InspireMD (NYSE: NSPR) reported a first-quarter loss of $3.82 per share, much wider than the loss of $2.50
AngioDynamics misses Q3 earnings
AngioDynamics (NASDAQ: ANGO) posted third-quarter earnings on Tuesday before the regular trading hours. Net sales for the period increased 3% to $86.3 million,
AngioDynamics second-quarter results beat market estimates
AngioDynamics posted second-quarter earnings on Friday, Jan. 4. before trading hours. Net sales for the period inched 5.5% to $91.5 million, with diluted
Johnson & Johnson dips on revenue decline in India
Johnson & Johnson (JNJ) shares fell 1% on Thursday after the company reported a 3% sales dip in India in the year
AngioDynamics stock plummets on Q1 earnings miss
AngioDynamics (ANGO) reported first quarter earnings of $0.16 per share, which missed analyst estimates. However, the medical device maker’s top line surpassed
Medtronic to acquire Mazor for $1.64 billion
Medtronic plc (MDT) has agreed to buy Mazor Robotics for $1.64 billion. The all-cash deal, which amounts to $29.25 per ordinary share,